Travel-associated dengue illnesses among Wisconsin residents, 2002-2008

Wisconsin Medical Journal

Volumn 108, Issue 9, 2009, Pages 447-452

  Sotir, Mark J ^a,b   Johnson, Diep K Hoang ^a   Davis, Jeffrey P ^a  

^a WISCONSIN DIVISION OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; INSECT REPELLENT;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARBOVIRUS; ARTICLE; BLOOD SAMPLING; CARIBBEAN ISLANDS; CENTRAL AMERICA; CHILD; CLINICAL ARTICLE; DENGUE; ENDEMIC DISEASE; FEMALE; FEVER; HEADACHE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTERVIEW; LABORATORY TEST; MALE; MEXICO; MORTALITY; MOSQUITO; MYALGIA; RETROSPECTIVE STUDY; SCHOOL CHILD; SYMPTOM; TRAVEL; TRAVEL ASSOCIATED DENGUE; TROPICS; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; DENGUE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRAVEL; WISCONSIN;

EID: 77649285581     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480-496.
2. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002;33:330-342.
3. Rigau-Perez JG, Laufer MK. Dengue-related deaths in Puerto Rico, 1992-1996: diagnosis and clinical alarm signals. Clin Infect Dis. 2006;42:1241-1246.
4. Centers for Disease Control and Prevention. Traveler's Health-Yellow Book: Other Infectious Diseases Related to Travel. http://wwwnc.cdc.gov/travel/ yellowbook/2010/chapter-5/dengue-fever-dengue-hemorrhagic-fever.aspx. Accessed December 1, 2009.
5. Schwartz E, Weld LH, Wilder-Smith, et al. Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006. Emerg Infect Dis. 2008;14:1081-1088.
6. Ramos MM, Mohammed H, Zielinski-Gutierrez E, et al. Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, September 2005. Am J Trop Med Hyg. 2008;78(3):364-369.
7. Wilder-Smith A, Schwartz E. Dengue in Travelers. N Engl J Med. 2005;353:924-932.
8. Lindback H, Lindback J, Tegnell A, Janzon R, Vene S, Ekdahl K. Dengue fever in travelers to the tropics, 1998 and 1999. Emerg Infect Dis. 2003;9:438-442.
9. CDC. Travel-associated dengue infections - United States, 2001-2004. MMWR. 2005;54:556-558.
10. CDC. Travel-associated dengue - United States, 2005. MMWR. 2006;55:700-702.
11. Rigau-Perez JG, Gubler DJ, Vorndam AV, Clark GG. Dengue: a literature review and case study of travelers from the United States, 1986-1994. J Travel Med. 1997;4:65-71.
12. CDC. Outbreak Notice. Update: Dengue, tropical and subtropical regions. http://wwwn.cdc.gov/travel/contentDengue-TropicalSubTropical.aspx. Accessed November 30, 2009.
13. CDC. Dengue fever (dengue hemorrhagic fever) 1996 case definition. http://www.cdc.gov/ncphi/disss/nndss/print/dengue-fever-current.htm. Accessed November 30, 2009.
14. Wilder-Smith A, Chen LH, Massad E, Wilson ME. Threat of dengue to blood safety in dengue-endemic countries. Emerg Infect Dis. 2009;15:8-11.
15. Wichmann O, Stark K, Shu PY, et al. Clinical features and pitfalls in the laboratory diagnosis of dengue in travelers. BMC Infect Dis. 2006;6:120.
16. Dengue and dengue hemorrhagic fever: Information for health care providers. http://www.cdc.gov/ncidod/dvbid/dengue/dengue-hcp.htm. Accessed November 30, 2009.
17. Dengue fever. In Heymann DL (ed.). Control of Communicable Diseases Manual. 19th Ed. Washington, DC: American Public Health Association; 2008:164-168.
18. Hunsperger EA, Yoksan S, Buchy P, et al. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. EID. 2009;15:436-440.
19. Munoz-Jordan JL, Collins CS, Vergne E, et al. Highly sensitive detection of dengue virus nucleic acid in samples from clinically ill patients. J Clin Microbiol. 2009;47:927-931.
20. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis. 1997;176:322-330.
21. Jury MR. Climate influence on dengue epidemics in Puerto Rico. Int J Environ Health Res. 2008;18(5):323-334.
22. CDC. Health information for international travel, 2010. Chapter 5: Other infectious diseases related to travel. Dengue fever (DF) and dengue hemorrhagic fever (DHF). Tomashek KM (ed). http://www.cdc.gov/travel/yellowbook/2010/ chapter-5/dengue-fever-dengue-hemorrhagicfever.aspx. Accessed November 30, 2009.
23. Halstead SB, Nimmannitya, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med. 1970;42:311-328.
24. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988;38:172-180.
25. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2-9.